Dr. Thomas J. FitzGerald

Thomas J. FitzGerald

Thomas J. FitzGerald
Thomas J.
Radiation Oncologist

Languages spoken


Interested in

Prostate, Breast, Lung, Colorectal, Head and Neck Malignancies



Southbridge (Radiation oncology)
Southbridge (Radiation oncology)

55 Sayles Street
Southbridge, Massachusetts 01550


As the Principal Investigator of the National Cancer Institute (NCI) funded Quality Assurance Review Center, Dr. Thomas J. FitzGerald is responsible for quality of NCI cooperative group clinical trials and both national and international industry partners.

Career positions

Current position

  • Radiation Oncologist, GenesisCare

Past position(s)

  • University of Massachusetts Memorial Healthcare Systems - Director, Radiation Oncology, Worcester, MA
  • University of Massachusetts Medical School - Professor and Chair Department of Radiation Oncology, Worcester, MA
  • University of Massachusetts Medical School - Director, Quality Assurance Review Center, Department of Radiation Oncology, Worcester, MA



  • University of San Francisco, Bachelor's of Science in Biology, San Francisco, CA
  • University of Massachusetts Medical School, Doctor of Medicine, Worcester, MA


  • George Washington Hospital, Internal Medicine, Washington DC


  • Harvard Medical School, Dana Farber Cancer Institute, Radiation Oncology, Boston, MA

Professional association



  • Peer Recognition Award for Outstanding Clinical Service at University of Massachusetts Medical Center
  • Molseed Graduation Award
  • Cum laude at University of Missouri
  • George Washington University Hospital Outstanding Intern
  • ASTRO Annual Essay Award


  • Practice patterns and recommendations for pediatric image-guided radiotherapy: A Children's Oncology Group report
  • MD 1924 to 2020
  • Treatment Toxicity: Radiation.
  • Cardiac-Sparing Whole Lung IMRT in Patients With Pediatric Tumors and Lung Metastasis: Final Report of a Prospective Multicenter Clinical Trial.
  • An in-silico quality assurance study of contouring target volumes in thoracic tumors within a cooperative group setting
  • An Analysis of Major Target Deviations in Craniospinal Irradiation Treatment Plans for Patients With Intermediate-Risk Medulloblastoma Within a Phase 3 Clinical Trial (Children's Oncology Group Study ACNS0331) View publication
  • Definitive Radiation Therapy for Medically Inoperable Endometrial Carcinoma View publication
  • Extranodal presentation in limited stage diffuse large B-cell lymphoma as a prognostic marker in three SWOG trials S0014, S0313 and S1001 View publication
  • A Review of Concurrent Chemo/Radiation, Immunotherapy, Radiation Planning, and Biomarkers for Locally Advanced Non-small Cell Lung Cancer and Their Role in the Development of ECOG-ACRIN EA5181. View publication
  • Radiation Oncology: Future Vision for Quality Assurance and Data Management in Clinical Trials and Translational Science. View publication

Thank you for submitting.

We will be in touch within 24 hours.

An unexpected error has occurred.

You will need to complete the form again, sorry for the inconvenience.

How can we help?

Our staff will provide answers to your questions within 24 hours. Otherwise, if you have a medical emergency please call 911.

*Indicates a required field